NCT03325946

Brief Summary

The FBRI VTC Neuromotor Research Clinic was established and opened in May of 2013 to provide intensive therapeutic services to individuals with motor impairment secondary to neuromotor disorders. It is direct by Dr. Stephanie DeLuca and based on the principles surrounding ACQUIREc Therapy. ACQUIREc Therapy is an evidenced-based approach to pediatric constraint-induced movement therapy, which refers to a multi-component form of therapy that is focused on helping children who have asymmetric motor abilities between the two sides of the body. Historically, ACQUIREc Therapy has the unimpaired or less impaired upper extremity constrained (by a cast or a splint) while also receiving active therapy from a specially trained therapist who shapes new skills and functional activities with the child's more impaired upper extremity but who is also a licensed Occupational or Physical Therapist (OT/PT). Therapy dosages are high much higher than tradition OT or PT - often lasting many hours per day, up to 6 hours a day, 5 days a week, for 2-4 weeks. Investigators have developed further treatments based on the same principles of intensive services combined with behavior shaping for other areas of the body that are also affected by weakness (e.g., the leg and trunk) also, but which usually do not involve constraint. These have been more generally labeled ACQUIRE Therapy. All forms involve intensive, play-based therapy for children with asymmetric motor impairments of the arms and hands. The primary focus of treatment is to facilitate the acquisition of new motor skills in the child's weaker body parts through high levels of intensive therapy using scientifically-based behavioral guidelines. Therapy is also delivered in naturalistic environments. ACQUIREc Therapy as a treatment method has been tested in two randomized controlled trials, and a specific manual for its implementation has been developed. Dr. (s) Ramey and DeLuca previously founded a similar clinic, The Pediatric Neuromotor Research Clinic, at the University of Alabama at Birmingham where Dr. DeLuca directed the research clinic for 13 years and oversaw the implementation of the ACQUIREc Therapy treatment protocol in more than 400 cases. This research will involve analyzing and interpreting the clinical data of children going through clinical procedures at the FBRI VTC Neuromotor Research Clinic. All participation is voluntary and no children will denied services if families choose not to participate.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
43mo left

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jan 2013Dec 2029

Study Start

First participant enrolled

January 1, 2013

Completed
4.8 years until next milestone

First Submitted

Initial submission to the registry

October 9, 2017

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 30, 2017

Completed
12.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

17 years

First QC Date

October 9, 2017

Last Update Submit

January 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Emerging Behaviors Scale

    This is a measure of the number of skills a child uses from a set of 31 typical used on a daily basis

    up to 12 months

Secondary Outcomes (4)

  • Assisting Hand Assessment

    Within 1 week prior to treatment and Within 1 week after treatment

  • Pediatric Motor Activity Log

    Within 1 week prior to treatment and Within 1 week after treatment

  • Peabody Developmental Motor Scales 2

    Within 1 week prior to treatment and Within 1 week after treatment

  • The Bayley Motor Scales of Infant Development -III

    Within 1 week prior to treatment and Within 1 week after treatment

Other Outcomes (1)

  • Video Assessments

    Within 1 week prior to treatment, during treatment, and Within 1 week after treatment

Study Arms (4)

Children and Adults with Cerebral Palsy

Behavioral: ACQUIRE Therapy

Children and Adults with Microcephaly

Behavioral: ACQUIRE Therapy

Children and Adults with other Neuromotor Impairments

Behavioral: ACQUIRE Therapy

Children who have had a stroke

Behavioral: ACQUIRE Therapy

Interventions

ACQUIRE TherapyBEHAVIORAL

Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs

Children and Adults with Cerebral PalsyChildren and Adults with MicrocephalyChildren and Adults with other Neuromotor ImpairmentsChildren who have had a stroke

Eligibility Criteria

Age3 Months - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals with neuromotor impairment who want to try and gain motor skills and function

You may qualify if:

  • Neuromotor Impairment

You may not qualify if:

  • fragile health

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fralin Biomedical Research Institute - VTC

Roanoke, Virginia, 24016, United States

RECRUITING

Related Publications (2)

  • Wallace DA, Rebekah Trucks M, DeLuca SC. Clinical use of ACQUIRE Therapy for Children Diagnosed With CASK-Gene Related Disabilities. Adv Rehabil Sci Pract. 2024 Nov 27;13:27536351241302852. doi: 10.1177/27536351241302852. eCollection 2024 Jan-Dec.

  • DeLuca SC, Wallace DA, Trucks MR, Mukherjee K. A clinical series using intensive neurorehabilitation to promote functional motor and cognitive skills in three girls with CASK mutation. BMC Res Notes. 2017 Dec 19;10(1):743. doi: 10.1186/s13104-017-3065-z.

MeSH Terms

Conditions

Cerebral PalsyMicrocephalyAutistic DisorderBrain Injuries, TraumaticBrain Injuries

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesMalformations of Cortical Development, Group IMalformations of Cortical DevelopmentNervous System MalformationsCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAutism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Stephanie DeLuca, PhD

    Virginia Polytechnic Institute and State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stephanie DeLuca, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 9, 2017

First Posted

October 30, 2017

Study Start

January 1, 2013

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2029

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Data is released only with participant (parental/ guardian) permission

Locations